The telehealth company beat revenue expectations but missed on earnings per share. AmwellAmwell, the Boston-based telehealth company, saw its stock price go down 5.8% per share at market open on Friday, after releasing its first earnings report since its September IPO the night before. The company beat analyst expectations on revenue, but missed on earnings per share. In announcing its third quarter earnings, Amwell focused on technology investments and the launch of several new products, which co-CEO and chairman Ido Schoenberg says were “artificially accelerated” by the Covid-19 pandemic. He also says Amwell would like to get the benefit of Google’s national and global reach through the partnership.

Source: Forbes November 13, 2020 16:52 UTC